Noveris Health Sciences is trading at CA$0.24, 16.95% down amid continued selling pressure and elevated volatility.
- No company-specific announcement or confirmed catalyst was identified for August 14, 2026.
- Management previously said on August 6, 2026, it was unaware of any material operational change explaining unusual market activity.
- Broader markets are modestly higher, so macro sentiment does not clearly explain the decline.